Alfuzosin

Therapeutic Group

Drugs For Benign Prostatic Hypertrophy

Indication Dosage

Alfuzosin is a medication primarily prescribed to treat the symptoms of benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland in men. It works by relaxing the muscles in the prostate and the neck of the bladder, making it easier for urine to flow and alleviating common BPH symptoms such as difficulty urinating, frequent urination, and a weak urinary stream. 

Benign Prostatic Hyperplasia: 

  • Adult: 10 Mg Once Daily, 
  • Elderly: 5 Mg Morning And Evening. 
  • Children: Not Recommended. 

Acute Urinary Retention Associated With Benign Prostatic Hyperplasia: 

  • Elderly: 10 Mg Once Daily For 2-3 Days During Catheterisation And For One Day After Removal; Max. 4 Days

Content

  • Tab 2.5mg: Alfuzosin 2.5mg.
  • Sustained Release Tab 5mg /10mg: Alfuzosin 5mg /10mg.
  • XL Retard Tab 10mg: Alfuzosin 10mg.

Pregnancy

No Evidence Of Risk In Humans

Stability

  • Selective Alpha-1 Blocker

Contra Indications

  • History Of Orthostatic Hypotension, Avoid If History Micturition Syncope

Precautions

  • History Of Orthostatic Hypotension, Avoid If History Micturition Syncope

Lactation

  • Contraindicated, Avoid

Side Effects

  • Angioedema
  • Asthenia
  • Blurred Vision
  • Cholestasis
  • Depression
  • Dizziness
  • Drowsiness
  • Dry Mouth
  • Erectile Disorders (including Priapism)
  • gi Disturbances
  • Headache
  • Hypersensitivity
  • Hypotension
  • Intra-operative Floppy Iris Syndrome
  • Liver Damage
  • Oedema
  • Palpitations
  • Pruritus
  • Rash
  • Rhinitis
  • Syncope
  • Tachycardia
  • Hot Flushes
  • Chest Pain